Nav: Home

How the Ebola scare stigmatized African immigrants in the US

November 02, 2015

The deadly Ebola virus outbreak in West Africa also took its toll socially on one of the fastest growing populations in the United States, African immigrants. Guy-Lucien Whembolua, a University of Cincinnati assistant professor of Africana studies, leads an analysis of national news coverage of the Ebola scare in a poster presentation on Nov. 2, at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, in Chicago.

The examination reviewed reports in mainstream U.S. media related to African immigrants and the Ebola Virus Disease (EVD). The search turned up 21 news articles that matched the criteria for the study - articles focusing on African immigrants in the U.S. and the Ebola virus.

The researchers found that these African immigrants experienced stigma similar to communities stigmatized by the AIDS epidemic in the '80s. "There was strong discrimination against homosexual men during the AIDS epidemic and laying blame on that population for the spread of the virus," says Whembolua. "Similarly, in the early stages of the Ebola Virus outbreak in West Africa and amid sensationalized reports, we found a fear linked with African immigrants around spreading the disease in the U.S. Some of these populations felt they had to hide their ethnicity in an effort to avoid the stigma."

As a result, Whembolua says particularly in New York where there's a high Liberian immigrant population, there was a great deal of shame in being associated with Liberia. "Children were teased in high school, or adults were the butt of jokes at work. People from Nigeria also were stigmatized by the Ebola scare, resulting in stress and hardships for these populations," says Whembolua.

The researchers add that understanding this stigma faced by African communities in the U.S. could help improve health promotion programs targeting immigrants. They emphasize that the outbreak highlights a need for research on infectious disease that's relatively unknown in the U.S. and the Western world.

"There's more to the high death rate from the Ebola Virus in West Africa than just the virus itself," says Whembolua. "These countries don't have the infrastructures to combat the virus, and most of the populations affected already have low immune systems as the result of living in an impoverished country."

A Pew Research Center analysis of U.S. Census Bureau data, reported last spring, found that the black immigrant population in the U.S. is more than four times the number it was in 1980, and rapid growth is expected to continue.

Future UC research involving focus groups with populations stigmatized by the Ebola scare is currently under development in collaboration with Binghamton University.
-end-
Other researchers on the project include Donaldson Conserve, a postdoctoral research fellow at University of North Carolina at Chapel Hill; Daudet Ilunga Tshiswaka, a graduate student in the Department of Kinesiology and Community Health, University of Illinois-Champaign; Muswamba Mwamba, a graduate student in the Gillings School of Global Health, University of North Carolina, Chapel Hill; and Michael Gaisie, an undergraduate student in the UC School of Human Services in the College of Education, Criminal Justice, and Human Services.

Whembolua is program chair of the APHA's Caucus on Refugee and Immigrant Health and has served in that position since 2014. He is also director of UC's Africana Health Research Laboratory in the McMicken College of Arts and Sciences.

The American Public Health Association is the oldest and most diverse organization of public health professionals in the world and is dedicated to improving public health.

UC's Africana Studies Department in the McMicken College of Arts and Sciences is devoted to the academic study of the history, culture, health and politics of African, African-American, Afro-Latin, Afro-Caribbean and Afro-European populations.

University of Cincinnati

Related Ebola Virus Articles:

Tulane researchers help find possible explanation for unparalleled spread of Ebola virus
The world may be closer to knowing why Ebola spreads so easily thanks to a team of researchers from Tulane University and other leading institutions who discovered a new biological activity in a small protein from the deadly virus.
New CDISC data standard aids development of therapies for Ebola virus
The Clinical Data Interchange Standards Consortium (CDISC) and the Infectious Diseases Data Observatory (IDDO) announce the availability of a new standard to assist in the collection, aggregation and analysis of Ebola virus disease (EVD) research data.
Silence is golden -- Suppressing host response to Ebola virus may help to control infection
The Ebola virus causes a severe, often fatal illness when it infects the human body.
How do Ebola virus proteins released in exosomes affect the immune system?
Cells infected by the deadly Ebola virus may release viral proteins such as VP40 packaged in exosomes, which, as new research indicates, can affect immune cells throughout the body impairing their ability to combat the infection and to seek out and destroy hidden virus.
Blood test can predict life or death outcome for patients with Ebola virus disease
Scientists have identified a 'molecular barcode' in the blood of patients with Ebola that can predict whether they are likely to survive or die from the viral infection.
NIH scientists identify early impact of Ebola virus on immune system
A new mouse model of early Ebola virus (EBOV) infection has shown National Institutes of Health (NIH) scientists and colleagues how early responses of the immune system can affect development of EBOV disease.
Could co-infection with other viruses affect the survival of those with Ebola virus?
Could co-infection with other viruses have a detrimental affect on Ebola survival, and why did some show Ebola symptoms without having the virus?
Researchers stress the need for research on Ebola virus disease in great apes
Ebola virus disease (EVD) is a threat to human health, but it also threatens the survival of African great apes.
Antimalarial being tested as possible Ebola virus drug
The National Center for Advancing Translational Sciences (NCATS) recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc.
Antibodies from Ebola survivors neutralize virus, protect against infection in lab mice
A study by scientists at the Emory Vaccine Center, in collaboration with the biotechnology company Atreca, Inc., has found that antibodies generated from the blood of survivors of Ebola virus disease can strongly neutralize the Ebola virus in the laboratory and protect mice from a lethal viral challenge.

Related Ebola Virus Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...